A Feline‐Specific Anti‐Nerve Growth Factor Antibody Improves Mobility in Cats with Degenerative Joint Disease–Associated Pain: A Pilot Proof of Concept Study
Main Authors: | Gruen, M.E., Thomson, A.E., Griffith, E.H., Paradise, H., Gearing, D.P., Lascelles, B.D.X. |
---|---|
Format: | Online |
Language: | English |
Published: |
John Wiley and Sons Inc.
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153962/ |
Similar Items
-
Detection of Clinically Relevant Pain Relief in Cats with Degenerative Joint Disease Associated Pain
by: Gruen, M.E., et al.
Published: (2014) -
Relationship Between Degenerative Joint Disease, Pain, and Bartonella spp. Seroreactivity in Domesticated Cats
by: Tomas, A., et al.
Published: (2014) -
In Vitro and In Vivo Characterization of a Fully Felinized Therapeutic Anti‐Nerve Growth Factor Monoclonal Antibody for the Treatment of Pain in Cats
by: Gearing, D.P., et al.
Published: (2016) -
Criterion Validation Testing of Clinical Metrology Instruments for Measuring Degenerative Joint Disease Associated Mobility Impairment in Cats
by: Gruen, Margaret E., et al.
Published: (2015) -
Association of Canine Osteosarcoma and Monocyte Phenotype and Chemotactic Function
by: Tuohy, J.L., et al.
Published: (2016)